Description of Medical Areas
About the FDA Approved Listings
|
 |
Drugs Approved by the FDA (1998)
|
The following drugs have been approved this year by
the Food and Drug Administration.
Cardiology/Vascular Diseases
|
|
Agrylin; Treatment for Thrombocythemia; Roberts Pharmaceutical; Approved December 1998 Atacand; Treatment for hypertension; Astra Merck; Approved June 1998 CellCept; Treatment for the prevention of organ rejection inpatients undergoing heart transplants; Roche; Approved February 1998 Diovan HCT; Treatment for hypertension; Novartis; Approved March 1998 Integrilin; Injection of eptifibatide; COR Therapeutics, Key Pharmaceuticals; Approved May 1998 Micardis; Treatment for Hypertension; Boehringer Ingelheim; Approved November 1998 Rythmol; Treatment for paroxysmal atrial fibrillation; Knoll Pharmaceutical; Approved January 1998 Tiazac; Treatment for chronic stable angina; Forest Laboratories; Approved February 1998 Tiazac; Treatment for chronic stable angina; Forest Laboratories; Approved February 1998 Tricor; Treatment for very high triglyceride levels; Abbott Laboratories; Approved February 1998 Viagra; Treatment for impotence; Pfizer; Approved March 1998
Dental/Maxillofacial Surgery
|
|
Atridox therapy; Treatment for periodontal disease; Atrix Laboratories; Approved September 1998 Periostat; Treatment for periodontitis.; CollaGenex Pharmaceuticals; Approved October 1998
Dermatology/Plastic Surgery
|
|
Avita Gel; Treatment for acne; Penederm; Approved February 1998 Dynabac; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections); Sanofi Pharmaceuticals; Approved March 1998 Lustra; Treatment for ultraviolet-induced skin discolorations; Medicis Pharmaceutical; Approved January 1998 MetroLotion; Treatment of inflammatory papules and pustules of rosacea; Galderma Laboratories; Approved November 1998 Noritate; Treatment for rosacea; Dermik Laboratories; Approved January 1998 Salagen Tablets; Treatment for Sjogren's Syndrome; MGI Pharma; Approved February 1998 Sulfamylon; Treatment used to control bacterial infections on excised burn wounds; Mylan Laboratories; Approved June 1998 Thalomid; Treatment for moderate to severe erythema nodosum leprosum (ENL); Celgene; Approved July 1998
Actonel; Treatment for Paget's Disease; Procter & Gamble, Hoechst Marion Roussel; Approved April 1998 Arava; Treatment for Rheumatoid Arthritis; Hoechst Marion Roussel; Approved September 1998 Atacand; Treatment for hypertension; Astra Merck; Approved June 1998 Celexa; Treatment for depression; Forest Laboratories; Approved July 1998 CellCept; Treatment for the prevention of organ rejection inpatients undergoing heart transplants; Roche; Approved February 1998 Diovan HCT; Treatment for hypertension; Novartis; Approved March 1998 Esclim; Treatment for symptoms associated to Menopause; Fournier Research; Approved August 1998 Estratab (.3 mg ); Treatment for the prevention of osteoporosis; Solvay Pharmaceuticals; Approved March 1998 Glucagon; Treatment for severe Hypoglycemia; Eli Lilly; Approved September 1998 Glucagon; Treatment for severe hypoglycemia associated with diabetes.; Eli Lilly; Approved October 1998 Glyburide Tablets; Treatment for Diabetes Mellitus (Type II); Mylan Laboratories; Approved July 1998. Herceptin; Treatment for metastatic breast cancer; Genentech; Approved October 1998 Mircette; Oral contraceptive; Organon; Approved April 1998 Prempro; Treatment for hormone replacement therapy; Wyeth-Ayerst Laboratories; Approved January 1998 Prometrium; Treatment for Endometrial Hyperplasia; Schering; Approved December 1998 Proscar; Treatment for complication relating to benign prostatic hyperplasia (BPH); Merck; Approved April 1998 Simulect; Treatment for acute organ transplant rejection; Novartis; Approved May 1998 Xeloda; Treatment for advanced breast cancer tumors; Roche; Approved April 1998 Zemplar; Treatment of secondary hyperparathyroidism associated with chronic renal failure; Abbott Laboratories; Approved April 1998
Cimetidine; Generic equivalent of Tagamet HB 200; Pharmaceutical Formulations; Approved June 1998 Prilosec; Treatment for heartburn; Astra Merck; Approved January 1998
Actonel; Treatment for Paget's Disease; Procter & Gamble, Hoechst Marion Roussel; Approved April 1998 Droxia; Treatment for sickle-cell anemia; Bristol-Myers Squibb; Approved March 1998 Glucagon; Treatment for severe Hypoglycemia; Eli Lilly; Approved September 1998 Lovenox; Treatment for prevention of blood clots following hip-replacement surgery; Rhone Poulenc Rorer; Approved February 1998 Neupogen; Treatment for slow white blood cell recovery following chemotherapy; Amgen; Approval April 1998 Refludan; Treatment of heparin-induced thrombocytopenia type II; Hoechst Marion Roussel; Approved March 1998
Immunology/Infectious Diseases
|
|
Allegra-D; Treatment for nasal congestion due to seasonal allergy; Hoechst Marion Roussel; Approved March 1998 CellCept; Treatment for the prevention of organ rejection inpatients undergoing heart transplants; Roche; Approved February 1998 Dynabac; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections); Sanofi Pharmaceuticals; Approved March 1998 Simulect; Treatment for acute organ transplant rejection; Novartis; Approved May 1998 Timentin; Treatment for wide range of infections in children; SmithKline Beecham; Approved January 1998 Viroptic; Treatment for inflammation of the cornea in children due to herpes simplex virus; King Pharmaceuticals; Approved February 1998
Actonel; Treatment for Paget's Disease; Procter & Gamble, Hoechst Marion Roussel; Approved April 1998 Estratab (.3 mg ); Treatment for the prevention of osteoporosis; Solvay Pharmaceuticals; Approved March 1998 Etodolac tablets; Generic equivalent of Lodine 500 mg tablets; Faulding; Approved May 1998 Lodine XL; Treatment for arthritis; Wyeth-Ayerst Laboratories; Approved February 1998 Lovenox; Treatment for prevention of blood clots following hip-replacement surgery; Rhone Poulenc Rorer; Approved February 1998
Detrol tablets; Treatment for an overactive bladder; Pharmacia & Upjohn; Approved March 1998 Proscar; Treatment for complication relating to benign prostatic hyperplasia (BPH); Merck; Approved April 1998 RenaGel; Treatment for Renal Disease; Geltex; Approved November 1998 Simulect; Treatment for acute organ transplant rejection; Novartis; Approved May 1998 Zemplar; Treatment of secondary hyperparathyroidism associated with chronic renal failure; Abbott Laboratories; Approved April 1998
Amerge; Treatment for acute migraine; GlaxoWellcome; Approved February 1998 Clonazepam; Generic equivalent of Klonopin; Watson Pharmaceuticals; Approved January 1998 Cylert; Treatment for Attention Deficit Disorder; Abbott Laboratories; Approved October 1998 Excedrin Migraine; Treatment for mild to moderate migraine pain; Bristol-Myers Squibb; Approved January 1998 Maxalt; Acute treatment of migraine headache; Merck; Approved June 1998 Tasmar; Treatment for Parkinson's Disease; Roche; Approved January 1998
Esclim; Treatment for symptoms associated to Menopause; Fournier Research; Approved August 1998 Estratab (.3 mg ); Treatment for the prevention of osteoporosis; Solvay Pharmaceuticals; Approved March 1998 Herceptin; Treatment for metastatic breast cancer; Genentech; Approved October 1998 Micardis; Treatment for Hypertension; Boehringer Ingelheim; Approved November 1998 Mircette; Oral contraceptive; Organon; Approved April 1998 Prempro; Treatment for hormone replacement therapy; Wyeth-Ayerst Laboratories; Approved January 1998 Prometrium; Treatment for amenorrhea (abnormal cessation of menses); Solvay Pharmaceuticals; Approved May 1998 Prometrium; Treatment for Endometrial Hyperplasia; Schering; Approved December 1998 Xeloda; Treatment for advanced breast cancer tumors; Roche; Approved April 1998
Actiq; Treatment for Cancer Pain; Anesta Corporation; Approved November 1998 Anzemet; Treatment for the prevention of nausea and vomiting associated with chemotherapy and surgery; Hoechst Marion Roussel; Approved February 1998 Camptosar; Treatment for Colon or Rectal Cancer; Pharmacia & Upjohn; Approved October 1998 Gemzar; Treatment for Lung Cancer; Eli Lilly; Approved August 1998 Herceptin; Treatment for metastatic breast cancer; Genentech; Approved October 1998 Neupogen; Treatment for slow white blood cell recovery following chemotherapy; Amgen; Approval April 1998 Nolvadex; Treatment for Breast Cancer; Zeneca Pharmaceuticals; Approved October 1998 Photofrin; Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer; QLT; Approved January 1998 Proleukin; Treatment for metastatic melanoma; Chiron Corporation; Approved January 1998 Valstar; Treatment for Bladder Cancer; Anthra Pharmaceuticals; Approved October 1998 Xeloda; Treatment for advanced breast cancer tumors; Roche; Approved April 1998 Zofran; Treatment for postoperative vomiting and nausea in adults; GlaxoWellcome; Approved April 1998
Alrex; Treatment for seasonal allergic conjunctivitis; Bausch & Lomb, Pharmos; Approved March 1998 Cosopt; Treatment for glaucoma or ocular hypertension; Merck; Approved April 1998 Lotemax; Treatment for post-operative eye inflammation; Bausch & Lomb, Pharmos; Approved March 1998 Salagen Tablets; Treatment for Sjogren's Syndrome; MGI Pharma; Approved February 1998 Viroptic; Treatment for inflammation of the cornea in children due to herpes simplex virus; King Pharmaceuticals; Approved February 1998 Vitravene Injection; Treatment for CMV in AIDS patients; Isis Pharmaceuticals; Approved August 1998
Rocephin; Treatment for pediatric otitis media; Roche; Approved January 1998 Rocephin; Treatment for acute otitis media; Roche; Approved January 1998
Curosurf; Treatment for respiratory distress syndrome in premature infants.; Dey Laboratories; Approved October 1998 Cylert; Treatment for Attention Deficit Disorder; Abbott Laboratories; Approved October 1998 Infasurf; For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants; ONY; Approved July 1998. Rocephin; Treatment for pediatric otitis media; Roche; Approved January 1998 Rocephin; Treatment for acute otitis media; Roche; Approved January 1998 Singulair; Treatment for asthma; Merck; Approved February 1998 Timentin; Treatment for wide range of infections in children; SmithKline Beecham; Approved January 1998 Viroptic; Treatment for inflammation of the cornea in children due to herpes simplex virus; King Pharmaceuticals; Approved February 1998
Celexa; Treatment for depression; Forest Laboratories; Approved July 1998 Cylert; Treatment for Attention Deficit Disorder; Abbott Laboratories; Approved October 1998 Prochlorperazine; Generic equivalent of SmithKline Beecham's Compazine; IVAX; Approved January 1998
Pulmonary/Respiratory Diseases
|
|
Allegra-D; Treatment for nasal congestion due to seasonal allergy; Hoechst Marion Roussel; Approved March 1998 Curosurf; Treatment for respiratory distress syndrome in premature infants.; Dey Laboratories; Approved October 1998 Dynabac; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections); Sanofi Pharmaceuticals; Approved March 1998 Infasurf; For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants; ONY; Approved July 1998. Priftin; Treatment for pulmonary tuberculosis; Hoechst Marion Roussel; Approved June 1998 Singulair; Treatment for asthma; Merck; Approved February 1998 Synagis; Treatment for the prevention of serious lower respiratory tract disease in infants; MedImmune; Approved June 1998
Arava; Treatment for Rheumatoid Arthritis; Hoechst Marion Roussel; Approved September 1998 Lodine XL; Treatment for arthritis; Wyeth-Ayerst Laboratories; Approved February 1998 Salagen Tablets; Treatment for Sjogren's Syndrome; MGI Pharma; Approved February 1998
Trauma/Emergency Medicine
|
|
|
|
Back to Centerwatch Drug Directories
|
